178 related articles for article (PubMed ID: 33997269)
1. Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican.
von Spreckelsen N; Fadzen CM; Hartrampf N; Ghotmi Y; Wolfe JM; Dubey S; Yang BY; Kijewski MF; Wang S; Farquhar C; Bergmann S; Zdioruk M; Wasserburg JR; Scott B; Murrell E; Bononi FC; Luyt LG; DiCarli M; Lamfers MLM; Ligon KL; Chiocca EA; Viapiano MS; Pentelute BL; Lawler SE; Cho CF
Adv Ther (Weinh); 2021 Apr; 4(4):. PubMed ID: 33997269
[TBL] [Abstract][Full Text] [Related]
2. A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood-Brain Barrier Permeability and Targets Glioblastoma.
Cho CF; Farquhar CE; Fadzen CM; Scott B; Zhuang P; von Spreckelsen N; Loas A; Hartrampf N; Pentelute BL; Lawler SE
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565337
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
[TBL] [Abstract][Full Text] [Related]
5. C-X-C Chemokine Receptor Type 4-Targeted Imaging in Glioblastoma Multiforme Using
Zhang X; Detering L; Sultan D; Heo GS; Luehmann H; Taylor S; Choksi A; Rubin JB; Liu Y
ACS Appl Bio Mater; 2022 Jan; 5(1):235-242. PubMed ID: 35014818
[TBL] [Abstract][Full Text] [Related]
6. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
[TBL] [Abstract][Full Text] [Related]
8. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
9. Initial preclinical evaluation of 68 Ga-DOTA-(Ser) 3 -LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging.
Ranjbar V; Molavipordanjani S; Biabani Ardakani J; Akhlaghi M; Nikkholgh B; Hosseinimehr SJ
Nucl Med Commun; 2022 Aug; 43(8):945-951. PubMed ID: 35754162
[TBL] [Abstract][Full Text] [Related]
10. NTRK1 fusion in glioblastoma multiforme.
Kim J; Lee Y; Cho HJ; Lee YE; An J; Cho GH; Ko YH; Joo KM; Nam DH
PLoS One; 2014; 9(3):e91940. PubMed ID: 24647444
[TBL] [Abstract][Full Text] [Related]
11. Improved positron emission tomography imaging of glioblastoma cancer using novel
Loft MD; Sun Y; Liu C; Christensen C; Huang D; Kjaer A; Cheng Z
Amino Acids; 2017 Jun; 49(6):1089-1100. PubMed ID: 28316028
[TBL] [Abstract][Full Text] [Related]
12. A dual-targeting peptide for glioblastoma screened by phage display peptide library biopanning combined with affinity-adaptability analysis.
Li X; Pu X; Wang X; Wang J; Liao X; Huang Z; Yin G
Int J Pharm; 2023 Sep; 644():123306. PubMed ID: 37572856
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Biodistribution of
Ghosh S; Fletcher NL; Huda P; Houston ZH; Howard CB; Lund ME; Lu Y; Campbell DH; Walsh BJ; Thurecht KJ
Mol Pharm; 2023 Mar; 20(3):1549-1563. PubMed ID: 36602058
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
Chandrasekaran S; Hollander A; Xu X; Benci JL; Davis JJ; Dorsey JF; Kao G
ScientificWorldJournal; 2013; 2013():796029. PubMed ID: 23690748
[TBL] [Abstract][Full Text] [Related]
16. Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis.
Barbosa LC; Machado GC; Heringer M; Ferrer VP
Neurogenetics; 2024 May; ():. PubMed ID: 38775886
[TBL] [Abstract][Full Text] [Related]
17. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
Shi X; Xu P; Cao C; Cheng Z; Tian J; Hu Z
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4325-4337. PubMed ID: 35838757
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-Prostate-Specific Membrane Antigen-11 PET/CT: A New Imaging Option for Recurrent Glioblastoma Multiforme?
Kunikowska J; Kuliński R; Muylle K; Koziara H; Królicki L
Clin Nucl Med; 2020 Jan; 45(1):11-18. PubMed ID: 31663868
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
20. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
